Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
CN |
|
Javelin Minerals Ltd
ASX:JAV
|
AU |
|
I
|
Intel Corp
DUS:INL
|
US |
|
G
|
Great Western Bancorp Inc
F:2GW
|
US |
|
B
|
Beijing China Sciences Runyu Environmental Technology Co Ltd
SZSE:301175
|
CN |
|
G
|
GeeCee Ventures Ltd
NSE:GEECEE
|
IN |
|
Mirae ING Co Ltd
KRX:007120
|
KR |
|
Liberty Tripadvisor Holdings Inc
OTC:LTRPB
|
US |
|
A
|
AFP Planvital SA
SGO:PLANVITAL
|
CL |
Wall Street
Price Targets
Price Targets Summary
Jiangsu Hengrui Pharmaceuticals Co Ltd
According to Wall Street analysts, the average 1-year price target for
Jiangsu Hengrui Pharmaceuticals Co Ltd
is 80.84 CNY
with a low forecast of 50.5 CNY and a high forecast of 129.15 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Jiangsu Hengrui Pharmaceuticals Co Ltd's stock price target?
Price Target
80.84
CNY
According to Wall Street analysts, the average 1-year price target for
Jiangsu Hengrui Pharmaceuticals Co Ltd
is 80.84 CNY
with a low forecast of 50.5 CNY and a high forecast of 129.15 CNY.
What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Revenue forecast?
Projected CAGR
15%
For the last 14 years the
compound annual growth rate for
Jiangsu Hengrui Pharmaceuticals Co Ltd's revenue is
15%.
The projected
CAGR
for the next 3 years is
15%.
What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Operating Income forecast?
Projected CAGR
35%
For the last 14 years the
compound annual growth rate for
Jiangsu Hengrui Pharmaceuticals Co Ltd's operating income is
16%.
The projected
CAGR
for the next 3 years is
35%.
What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Net Income forecast?
Projected CAGR
20%
For the last 14 years the
compound annual growth rate for
Jiangsu Hengrui Pharmaceuticals Co Ltd's net income is
17%.
The projected
CAGR
for the next 2 years is
20%.
